Lifex BioLabs, Inc
Molecular pair offers potential for Parkinson’s treatment, finds NTU Singapore-Harvard study
A promising molecular pair has offered hope that could lead to the development of a new treatment to slow down Parkinson’s disease, a study by Nanyang Technological University, Singapore (NTU Singapore) and Harvard University has found.
2 Compounds Show Ability to Protect Neurons, Raise Dopamine Levels
Two compounds with hormone-like effects — prostaglandin E1 (PGE1) and prostaglandin A1 (PGA1) — may help to increase dopamine levels in the brain and slow Parkinson’s progression by activating a protein, called Nurr1,